From Basic Science to Better Medicines: A Conversation with Congresswoman Katherine Clark

Bentley’s Center for Integration of Science and Industry recently published a study in the Proceedings of the National Academy of Sciences that showed the National Institutes of Health (NIH) invested more than $100 billion in research that led to new medicines in the last decade. Significantly, NIH funding contributed to the basic science leading to every one of these new medicines.

We are honored that Massachusetts Congresswoman Katherine Clark will be visiting Bentley for a conversation about the essential role of government in funding basic biomedical science, and how the biotechnology industry builds on this science to create new medicines, jobs, and successful companies.


Lynne Rosansky, provost at Bentley University

Moderated by Center Director and Professor Fred Ledley

  • Ekaterina Cleary, research associate and lead author of the PNAS study
  • Deborah Dunsire, CEO of Xtuit Pharmaceuticals
  • Chris Garabedian, CEO of Xontogeny
  • Mark Namchuk, SVP of Research, Pharmaceutical and Non-clinical Development at Alkermes
  • Massachusetts Congresswoman Katherine Clark

Monday, April 23, 2018
10:00 am – 11:30 am
Jennison Hall, Room 125

RSVP: Mary.Davis@Bentley.edu  781.891.2254
We hope you will join us for this important and timely conversation.


Add to your Calendar: Add to Google CalendarAdd to Outlook / Download ICS « See More Events